EPA 2026: A Private Executive Dinner for Senior Pharma Leaders

A Focused Executive Exchange Before EPA 2026

The evening before the World Evidence, Pricing & Access Congress begins, Stratence Partners will host a private, invitation-only VIP Dinner in Amsterdam.

This event is designed for a highly curated group of senior global leaders (VP+ and C-level) across Pricing, Market Access, Commercial Strategy and Finance governance within major pharmaceutical organizations.

📍 Date: Monday, March 2

🕖 Time: 19:00

📍 Location: To be disclosed upon confirmation

The purpose is not networking volume — but discussion depth.

Why a Closed-Door Format

In large congress settings, strategic issues are often acknowledged but not dissected.

This dinner creates space for peer-level discussion on topics such as:

• Structural Gross-to-Net transparency and governance

• AI adoption beyond pilots and dashboards

• Alignment between pricing, access and finance

• Commercial execution discipline at scale

The format is intentionally limited to ensure meaningful participation and exchange among decision-makers.

Stratence and Andersen

Stratence Partners operates as a collaborating firm of Andersen Consulting within Andersen Global, integrating Commercial Transformation, Pricing Excellence and AI-Powered commercial systems into measurable EBIT impact.

Senior representatives present at the dinner will include:

• Fernando Ventureira – CEO

• Aleksandar Ruzicic

• Eduardo Kühnel

Requesting Participation

Attendance is limited.

If you are attending EPA 2026 and would value participating in a focused executive dialogue, please confirm interest directly at:

📩 fventureira@stratence.partners

Participation will be confirmed individually.

The most valuable conversations often happen before the conference officially begins.